Literature DB >> 18938755

"I have chosen to live life abundantly": perceptions of leisure by adults who use augmentative and alternative communication.

John Dattilo1, Gus Estrella, Laura J Estrella, Janice Light, David McNaughton, Meagan Seabury.   

Abstract

An online focus group was used to investigate perceptions of eight adults with cerebral palsy who used AAC systems about their recreation activities and leisure experiences. Six themes emerged from discussions on benefits of leisure and community recreation: improved physical health, enjoyment, improved mental health, increased independence, enhanced social connections, and education of society. Nine barriers to leisure participation were identified including: personal, social, communication, technology, financial, accessibility, safety, transportation, and personal care attendants. Despite numerous barriers to leisure, participants described six supports that helped them overcome these barriers: personal, social, family, personal care attendants, AAC devices, and other assistive technologies. Participants provided recommendations for other individuals who use AAC, their families, and service providers.

Entities:  

Mesh:

Year:  2008        PMID: 18938755     DOI: 10.1080/07434610701390558

Source DB:  PubMed          Journal:  Augment Altern Commun        ISSN: 0743-4618            Impact factor:   2.214


  3 in total

Review 1.  Cerebral palsy and aging.

Authors:  Peterson Haak; Madeleine Lenski; Mary Jo Cooley Hidecker; Min Li; Nigel Paneth
Journal:  Dev Med Child Neurol       Date:  2009-10       Impact factor: 5.449

2.  Exploring Winter Community Participation Among Wheelchair Users: An Online Focus Group.

Authors:  Jacquie Ripat; Angela Colatruglio
Journal:  Occup Ther Health Care       Date:  2015-08-21

3.  Development of a new high sensitivity mechanical switch for augmentative and alternative communication access in people with amyotrophic lateral sclerosis.

Authors:  M Caligari; M Godi; M Giardini; R Colombo
Journal:  J Neuroeng Rehabil       Date:  2019-11-29       Impact factor: 4.262

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.